Butyl Gallate

Butyl Gallate

SCHEMBL35913

CCCCOC(=O)c1cc(O)c(O)c(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 11/20 1.00
AKR1C4 P17516 1/20 0.87
AKR1C3 P42330 1/20 0.87
AKR1C2 P52895 1/20 0.87
AKR1C1 Q04828 1/20 0.87
SERPINE1 P05121 3/20 0.79
CNR1 P21554 1/20 0.66
CNR2 P34972 1/20 0.66
LMNA P02545 1/20 0.62
CYP1A2 P05177 1/20 0.62
CYP2D6 P10635 1/20 0.62
TSHR P16473 1/20 0.62
MAPK1 P28482 1/20 0.62
CYP2C19 P33261 1/20 0.62
NR1H2 P55055 1/20 0.62
RNASEL Q05823 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyl Gallate SCHEMBL27695996 0.95 ESR1 (0.90) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
Pentyl Gallate SCHEMBL505480 0.95 ESR1 (0.97) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL9061046 0.93 ESR1 (1.00) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
Octadecyl Gallate SCHEMBL51646 0.93 ESR1 (1.00) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
Dodecyl Gallate SCHEMBL7566739 0.93 ESR1 (1.00) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
Tetradecyl Gallate SCHEMBL221375 0.93 ESR1 (1.00) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
Octyl_Gallate SCHEMBL36234 0.93 ESR1 (1.00) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
Dodecyl Gallate SCHEMBL36820 0.93 ESR1 (1.00) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
Undecyl Gallate SCHEMBL2219566 0.93 ESR1 (1.00) ESR1AKR1C4AKR1C3AKR1C2AKR1C1
Nonyl Gallate SCHEMBL1260820 0.93 ESR1 (1.00) ESR1AKR1C4AKR1C3AKR1C2AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1530 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4680027-A1 A METHOD FOR IMPARTING ANTIMICROBIAL PROPERTIES TO A SYNTHETIC SUBSTRATE Biocompatibility Innovation Srl (IT) 2026-01-21 EP claimed
EP-4640247-A1 SLURRY FOR LOW-TEMPERATURE CURING OF CERAMIC POROUS BODY, AND METHOD FOR MANUFACTURING CERAMIC POROUS BODY Biotree Co., Ltd. (KR) 2025-10-29 EP claimed
US-20250275997-A1 Compositions Comprising S-Adenosylmethionine and a Gallic Acid Ester BONAFIDE HEALTH, LLC 2025-09-04 US claimed
EP-4604931-A1 COMPOSITIONS OF A DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND AN ANTIOXIDANT Merck Sharp & Dohme LLC (US) 2025-08-27 EP claimed
US-12303524-B2 Compositions comprising S-adenosylmethionine and a gallic acid ester MSI-195 HOLDINGS, LLC (US) 2025-05-20 US claimed
CN-119841360-A Method for preparing copper element doped nickel-iron-manganese precursor material and sodium battery positive electrode material thereof 中冶长天国际工程有限责任公司 2025-04-18 CN claimed
US-20250090566-A1 BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2025-03-20 US claimed
CN-119529147-A Hydrophilically modified blood purification adsorption resin and preparation method and application thereof 广州康盛生物科技股份有限公司 2025-02-28 CN claimed
CN-118833832-B Oil-ice semi-solid phase coprecipitation process for synthesizing Prussian blue type positive electrode material 哈尔滨工业大学 2025-02-07 CN claimed
CN-115895800-B Semi-water-based wafer substrate cleaning fluid composition and method of use 芯越微电子材料(嘉兴)有限公司 2024-12-27 CN claimed
WO-1997027360-A1 PHASE SEPARATION APPARATUS SCAPA GROUP PLC (GB) 1997-07-31 WO claimed
EP-0420893-B1 REDUCIBLE INDICATORS CONTAINING PYROGALLOL AND USE THEREOF BOEHRINGER MANNHEIM CORP (US) 1995-07-26 EP claimed
US-5397832-A Ester plasticizers ADVANCED ELASTOMER SYSTEMS, L.P. (US) 1995-03-14 US claimed
US-5290886-A Blends of olefin homo or copolymers with olefin rubbers and plasticizers ADVANCED ELASTOMER SYSTEMS, L.P. (US) 1994-03-01 US claimed
US-5084395-A A chromogen and a pyrogallol derivative as a detector BOEHRINGER MANNHEIM GMBH (DE) 1992-01-28 US claimed
EP-0420893-A4 REDUCIBLE INDICATORS CONTAINING PYROGALLOL AND USE THEREOF 1991-09-25 EP claimed
EP-0420893-A1 REDUCIBLE INDICATORS CONTAINING PYROGALLOL AND USE THEREOF. BOEHRINGER MANNHEIM CORP (US) 1991-04-10 EP claimed
US-4971918-A KIT WITH A DETECTABLE COLOR SIGNAL FOR DETECTION OF BLOOD, UR INE ETC FOR DRUGS, GLUCOSE BOEHRINGER MANNHEIM CORPORATION (US) 1990-11-20 US claimed
US-4963457-A Photosensitive, pressure-sensitive recording sheet of plain paper transfer type comprising wax MITSUBISHI PAPER MILLS, LTD (JP) 1990-10-16 US claimed
WO-1989011643-A1 REDUCIBLE INDICATORS CONTAINING PYROGALLOL AND USE THEREOF BOEHRINGER MANNHEIM CORPORATION (US) 1989-11-30 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250275997-A1 Compositions Comprising S-Adenosylmethionine and a Gallic Acid Ester BHMT2, BHMT, MAT1A ESR1 598/4885AKR1C4 1989/4885AKR1C3 1733/4885
US-20250090566-A1 BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF TOP1, DNA2, TOP2A ESR1 3076/4885AKR1C4 3115/4885AKR1C3 3534/4885
US-12303524-B2 Compositions comprising S-adenosylmethionine and a gallic acid ester BHMT2, BHMT, MAT1A ESR1 598/4885AKR1C4 1989/4885AKR1C3 1733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.